Intra-Cellular Therapies Inc.

Available to platforms
R StocksTrader
Intra-Cellular Therapies is a biopharmaceutical company based on the research of Paul Greengard, who received the Nobel Prize for revealing how treatment methods affect the internal workings of cells in the body.

Intra-Cellular Therapies Inc. - ITCI stocks live chart

Analyze price movements of Intra-Cellular Therapies Inc. online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous ITCI quotes – including the latest bid at 131.78 USD and ask at 132 USD – and get all the necessary information for adding Intra-Cellular Therapies Inc. to your investment portfolio.

With R StocksTrader, you can invest in Intra-Cellular Therapies Inc. and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Intra-Cellular Therapies Inc., and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of ITCI does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Intra-Cellular Therapies Inc. (ITCI).

You can trade Intra-Cellular Therapies Inc. (ITCI) on the R StocksTrader platform.

You can trade online Intra-Cellular Therapies Inc. (ITCI) on Prime, ECN, Pro, or R StocksTrader accounts.